International Scholarly Research Notices / 2013 / Article / Fig 1

Research Article

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy

Figure 1

(a) Percent CD4+, (b) percent CD8+, and (c) CD4+/CD8+ ratio in virologically suppressed patients. Line represents median; rank-sum test; BL: baseline.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.